The Fetal Fibronectin Test
© mahalie
The fetal fibronectin test is a a noninvasive test that can identify a woman's risk for premature birth: a negative test result reveals with 99 percent certainty that a woman will not deliver her baby within the next 14 days.
The fetal fibronectin test enables physicians to determine who is most appropriate for medical intervention while sparing many women from unnecessary treatment including powerful steroid drugs and hospitalization.
Yes. Premature birth can be detected. There is an FDA-approved, noninvasive test that provides physicians with valuable information about the likelihood that premature birth will occur. FullTermâ„¢, The Fetal Fibronectin Test is the single strongest independent predictor of preterm birth at less than 32 weeks.
Collection can be performed in a doctor's office (similar to a Pap smear test) and the test measures the amount of fetal fibronectin-the "glue" that holds the baby in the womb-in the vagina. During weeks 22 to 35 of a pregnancy, fetal fibronectin should be almost undetectable.
As prematurity is the number one cause of death among newborns in the United States, this noninvasive test is the closest thing to a magic ball when it comes to predicting which pregnant women may have complications resulting in babies who might have problems once delivered.
May 20th, 2009 at 9:11 am
I think it’s a success that this type of evidence proving such cases is important because an efficient and effective control to determine the stability of the fetus and the patient, we hope that many women take an appropriate measure for this test.
May 29th, 2009 at 12:18 pm
Thanks for the info! Your blog has very helpful resources.
August 27th, 2009 at 5:44 am
this test really is something. it will be a lot of help in pregnant women.